Andrew T. Kaplan, Director of Kailera Therapeutics KLRA, has filed 1 purchase and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $134.4M. The latest trade was on 04/20.

AK

AK

Andrew T. Kaplan

Director

Company

Kailera Therapeutics KLRA

First filing

23/12/21

Trades

6 trades

Buys / sales

1 / 1

12-month net buying

$134.4M

Last trade

04/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Kailera TherapeuticsKLRA	Open-market buy	04/20	04/20	8,398,438 sh	$16.00	$134,375,008	+47.0%
Surgery PartnersSGRY	Open-market sale	23/12/19	23/12/21	7,826,870 sh	$33.44	$261,730,532.8	−13.4%